| Financial Year |
March 31 2023 |
| Monetary Funds |
3,090,912,441.14 |
| Held-for-trading Financial Assets |
490,063,636.99 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,339,625,033.67 |
| Advances to Suppliers |
41,130,766.44 |
| Other Receivables |
27,966,251.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
723,861,721.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,119,950.15 |
| Total Current Assets |
6,753,300,171.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
146,157,025.39 |
| Investment Properties |
161,444,587.12 |
| Fixed Assetes |
755,889,868.83 |
| Under-construction Projects |
53,660,990.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
315,352,543.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
35,039,730.66 |
| Deferred Income Tax Assets |
46,043,987.50 |
| Other Non-Current Assets |
884,955.76 |
| Sub-Total of Non-Current Assets |
2,517,050,064.29 |
| Total Assets |
9,270,350,235.80 |
| Short-Term Loans |
2,037,239,584.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,405,140,382.19 |
| Accounts Payable |
604,948,249.28 |
| Accounts Received In Advance |
2,226,910.22 |
| Employee Compensation Payable |
74,223,764.68 |
| Taxes Payable |
103,324,424.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,611,594.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
698,817,449.13 |
| Other Current Liabilities |
9,411,198.25 |
| Sub-Total of Current Liabilities |
5,019,909,531.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,019,263.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
61,558,461.41 |
| Total Liabilities |
5,081,467,992.42 |
| Paid-In Capital(Or Share Stock) |
2,175,736,503.00 |
| Capital Surplus |
260,563,690.80 |
| Surplus Reserve |
330,496,103.63 |
| LESS:Treasury Stock |
28,648,921.32 |
| Undistributed Profits |
1,323,812,453.50 |
| Minority Stockholder's Interest |
29,305,991.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,159,576,252.08 |
| Owner's Equity（Stockholder's Equity） |
4,188,882,243.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,270,350,235.80 |
